Advertisement
St. Jude Medical
Subscribe to St. Jude Medical

The Lead

St. Jude Medical Resolves FDA Warning Letter for Sylmar Facility

July 2, 2014 9:14 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, announced that it has been notified by the U.S. Food and Drug Administration (FDA) that issues cited in the Sylmar, Calif., facility’s warning letter have been addressed. “We take...

First Alabamian Receives New Retrievable, Nonsurgical Pacemaker

June 23, 2014 8:53 am | by University of Alabama at Birmingham | News | Comments

Hoover resident Jack Brymer was driving home with his wife, Shirley, one night recently when it...

St. Jude’s Leadless Pacemaker Receives Prestigious Innovation Award

June 18, 2014 4:03 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced the Nanostim leadless...

Report on Medical Device Market Outlines Challenges, Opportunities for Cost Containment

May 30, 2014 3:44 pm | by Rich Gedney, CEO, ADMET | Blogs | Comments

The medical device market has experienced tremendous growth, reaching more than $330 billion...

View Sample

FREE Email Newsletter

POST-IT Clinical Registry Demonstrates Importance of St. Jude Medical Fractional Flow Reserve Technology at EuroPCR 2014

May 22, 2014 2:28 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced results from the POST-IT (Portuguese Study on the Evaluation of FFR Guided Treatment of Coronary Disease) registry were presented during a hot line late-breaking clinical...

Preliminary Results from the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014 2:15 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical Inc., a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation system provided safe and effective therapy for...

St. Jude Medical Announces First Implants in US Study of the Portico Transcatheter Aortic Heart Valve System

May 14, 2014 8:50 am | by St. Jude Medical Inc. | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial). The trial is evaluating the Portico...

Advertisement

Leadless Pacemaker Showing Promising Results After One-Year

May 9, 2014 1:34 pm | by PR Newswire | News | Comments

Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising 12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional...

Pacemaker and Defibrillator Patients Adhering to Remote Monitoring with St. Jude Medical's Merlin Technology Saw More than Double Survival Rate

May 8, 2014 6:13 pm | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, announced that data presented during a Late Breaking Clinical Trial Session during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found an association between...

Scripps Is First in Region to Implant Wireless Cardiac Pacemaker

April 23, 2014 3:39 pm | by PR Newswire | News | Comments

Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim™ leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical...

Heart Device Lawsuits Continue Against St. Jude Over Defective Riata Lead Wires

April 18, 2014 2:38 pm | by The Associated Press | News | Comments

The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads. In November 2011, the FDA issued a Class 1 recall of the St. Jude Medical Riata...

First Patient in U.S. to Receive MRI Scan in Clinical Study of MRI-Compatible Pacemaker

April 10, 2014 8:36 pm | by PR Newswire | News | Comments

Providence Saint Joseph Medical Center is the first hospital in the nation to conduct an MRI scan of a patient implanted with a new MRI-compatible pacemaker – a breakthrough because metal implants often exclude patients from this imaging...

Advertisement

St. Jude Medical Recognized as Innovative Technology Supplier of the Year

April 9, 2014 12:19 pm | by St. Jude Medical Inc. | News | Comments

St. Jude Medical, Inc., a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN PCI Optimization System based on their experience...

World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval

April 4, 2014 8:42 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the approval of its Protégé IPG from the U.S. Food and Drug Administration (FDA). Protégé is the first and only neurostimulation system that allows spinal cord stimulation...

Suit Charges St. Jude Riata Heart Lead Is a Defective Device

March 21, 2014 10:27 am | by Business Wire | News | Comments

Fabrice N. Vincent and Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, have announced that Robert Loiseau of Southampton, Pennsylvania, has filed a personal injury lawsuit against St. Jude...

European Launch of St. Jude's Spinal Cord Stimulation System with Burst Technology

March 20, 2014 8:31 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the CE Mark approval and European launch of its Prodigy Chronic Pain System with Burst Technology. As the first and only implantable neuromodulation system that delivers...

European Post-Approval Trial for St. Jude's Leadless Pacemaker Begins

March 18, 2014 8:26 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the first enrollments in the company’s LEADLESS Pacemaker Observational Study evaluating the Nanostim™ leadless pacing technology. The Nanostim pacemaker received CE...

Advertisement

Deep Brain Stimulation Devices Market for Parkinson's disease Expected to Reach USD 9.4 Billion Globally in 2019

March 18, 2014 7:28 am | by PR Newswire | News | Comments

According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth...

First U.S. Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

February 6, 2014 10:21 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the first U.S. implant in the company’s LEADLESS II pivotal trial designed to evaluate the Nanostim leadless pacemaker for U.S. Food and Drug Administration (FDA)...

St. Jude Medical Announces Implant of World’s First Leadless Pacemaker in the UK

January 27, 2014 1:12 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the first post-approval implant of the Nanostim leadless pacemaker in the U.K. The world’s first retrievable leadless pacemaker was implanted at St. Bartholomew’s Hospital...

St. Jude CEO: Medtronic's renal denervation miss doesn't dampen our spirits

January 13, 2014 5:55 pm | by Mass Device | News | Comments

St. Jude Medical CEO Daniel Starks remains steadfast in his pursuit of renal denervation in treatment of hypertension, despite the high-profile clinical trial flop suffered just last week by rival medtech titan Medtronic. St. Jude will continue with its...

St. Jude Medical beats guidance with Q4 prelims

January 13, 2014 9:03 am | by Mass Device | News | Comments

St. Jude Medical said it's likely to top the high end of its 4th-quarter outlook for both sales and earnings, predicting 4% revenue growth and a bottom-line gain of as much as 154% for the 3 months ended Dec. 28, 2013, compared with the same...

St. Jude Medical soars to new heights

January 2, 2014 5:28 pm | by Mass Device | News | Comments

Medical device giant St. Jude Medical ended 2013 with a boost, notching a new Wall Street high-water mark of $63.15 on December 26. Shares sank back down to close at $62.74 that day and have since dropped further to close at $61.71 today...

St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve

December 12, 2013 8:00 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval for its 25 mm Portico Transcatheter Aortic Heart Valve Implantation System. The approval expands the number of patients who can be treated using...

Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure

December 11, 2013 7:00 am | by Business Wire | News | Comments

AccessClosure Inc., the market leader in extravascular closure devices, has announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning...

St. Jude Medical halts Enlightn IV trial

December 10, 2013 3:30 pm | by Mass Device | News | Comments

St. Jude Medical is calling off the Enlightn IV trial of the next generation of its renal denervation technology, just a few months after it began. The trial of St. Jude's multi-electrode Enlightn device was slated to enroll about 590 patients...

St. Jude Medical Board of Directors Authorizes $700 Million Share Repurchase

December 9, 2013 4:25 pm | by Business Wire | News | Comments

St. Jude Medical, Inc. announced today that its Board of Directors has authorized a share repurchase of up to $700 million of its outstanding common stock. The repurchases will occur at such times and at such prices as the management of the...

St. Jude Medical Begins US Study to Evaluate Combination of Peripheral Nerve Field Stimulation and Spinal Cord Stimulation for Chronic Low Back and Leg Pain

December 4, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, has launched a clinical study to evaluate the combination of peripheral nerve field stimulation (PNfS), and spinal cord stimulation (SCS), to determine whether the two therapies together...

St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain

December 3, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, has initiated a clinical study of the Prodigy ™ neurostimulator, the first spinal cord stimulation (SCS) system able to deliver a proprietary mode of stimulation therapy called burst...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading